AmerisourceBergen’s ThinkLive Summit Focuses on Innovation & Patient Access
November 2, 2018
400 pharmaceutical manufacturers joined the healthcare solutions leader for two-day event
Forge, Pa. – Today, AmerisourceBergen, a global
healthcare solutions leader, concluded its annual two-day manufacturer summit ThinkLive
2018. The conference brought together more than 400 leading pharmaceutical
manufacturers and executives from across AmerisourceBergen to collaborate and
share insights around driving increased product access and success around the
Throughout the conference, AmerisourceBergen leaders underscored the importance of enhancing strategic partnerships to increase connectivity within the healthcare system and improve patient outcomes through pharmaceutical-led care. They also highlighted organizational initiatives centered around innovative technology and solutions to support the next generation of novel and cost-effective therapies, such as cell and gene and biosimilar products.
“At AmerisourceBergen, we see our role in healthcare as a critical link that connects all stakeholders – from the manufacturers developing lifesaving treatments, to the pharmacies and specialty physician practices dispensing and administering these products – with services and solutions that facilitate access and enable the best possible outcomes for patients,” said Akin Odutola, President of Strategic Global Sourcing at AmerisourceBergen. “As our industry continues to rapidly transform, it is our commitment and responsibility to drive innovation across the supply chain, and ultimately create a more efficient system to support the success of all of our partners and their patients.”
AmerisourceBergen discussed clinical advancements, technology-driven approaches to commercialization, and expanding specialty therapies in all sites of care. Two panel discussions focused on the evolution of community pharmacies and the importance of a coordinated care model. Recognizing that pharmacists are essential healthcare providers who can support proper adherence, manufacturers were able to hear first-hand the value each of these unique healthcare settings can provide patients.
In conjunction with these presentations, AmerisourceBergen also released the results of its first national pharmacy survey: Pharmacy Check-Up: Activities & Barriers to Care Analysis. The research quantified pharmacists’ current perceptions on the state of the industry, and identified the biggest opportunities, challenges and barriers pharmacists face in providing high-quality patient care.
AmerisourceBergen also recognized several companies for their contributions to shaping healthcare delivery, including:
- Shaping Healthcare Delivery Award for Generis: Mylan Pharmaceuticals
- Shaping Healthcare Delivery Award for Generics: Ascend Laboratories
- Shaping Healthcare Delivery Award for Brand & Specialty: Indivior
- Shaping Healthcare Delivery Award for Brand & Specialty: GlaxoSmithKline
- Shaping Healthcare Delivery Award for Consumer: Scott Specialties
- Shaping Healthcare Delivery Award for Consumer: Emerson Healthcare
is AmerisourceBergen’s annual conference focused on providing pharmaceutical
manufacturers with innovative, forward-looking and patient-centric solutions to
help maximize success at every stage of the product life cycle.
AmerisourceBergen provides pharmaceutical products, value-driving services and business solutions that improve access to care. Tens of thousands of healthcare providers, veterinary practices and livestock producers trust us as their partner in the pharmaceutical supply chain. Global pharmaceutical manufacturers depend on us for services that drive commercial success for their products. Powered by our 21,000 associates, we are united in our responsibility to create healthier futures. AmerisourceBergen is ranked #12 on the Fortune 500, with more than $150 billion in annual revenue. The company is headquartered in Valley Forge, Pa. and has a presence in 50+ countries. To learn more about AmerisourceBergen, go to www.amerisourcebergen.com.